Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions (original) (raw)

References

  1. Page, D. & DuPont, W. Anatomic indicators (histologic and cytologic) of increased breast cancer risk. Breast Cancer Res. Treat. 28, 157–166 (1993).
    Article CAS Google Scholar
  2. Page, D. & DuPont, W. Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66, 1326–1335 (1990).
    Article CAS Google Scholar
  3. DuPont, W. & Page, D. Risk factors for breast cancer in women with proliferative breast disease. New Engl. J. Med. 312, 146–151 (1985).
    Article CAS Google Scholar
  4. Buckley, M. et al. Expression and amplification of cyclin genes in human breast cancer. Oncogens 8, 2127–2133 (1993).
    CAS Google Scholar
  5. Keyomarsi, K. & Pardee, A. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. natn. Acad. Sci. U.S.A. 90, 1112–1116 (1993).
    Article CAS Google Scholar
  6. Crissman, J., Visscher, W. & Kubus, J. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast. Arch. Path. lab. Med. 114, 1249–1253 (1990).
    CAS PubMed Google Scholar
  7. Carpenter, R., Gibbs, N., Matthews, T. & Cooke, T. Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breast. Br. J. Surg. 74, 905–906 (1987).
    Article CAS Google Scholar
  8. Ohuchi, N. et al. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast. J. natn. Cancer Inst 79, 109–117 (1987).
    CAS Google Scholar
  9. Lodato, R., Maguire, H., Greene, M., Weiner, D. & LiVolsi, V. Immunohistochemical evaluation of c-erb-B-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Modern Path. 3, 449–454 (1990).
    CAS Google Scholar
  10. Umekita, Y., Takasaki, T. & Yoshida, H. Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: An immunohistochemical study. Virchows Archiv. 424, 491–494 (1994).
    Article CAS Google Scholar
  11. Tsuda, H., Iwaya, K., Fukutomi, T. & Hirohashi, S. p53 mutations and c-erb-B-2 amplification in intraductal and invasive breast carcinomas of high histological grade. Jpn. J. Cancer Res. 84, 394–401 (1993).
    Article CAS Google Scholar
  12. Poller, D., Roberts, E., Bell, J., Elston, C., Blamey, R. & Ellis, I. p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erb-B-2 protein. Hum. Path. 24, 463–468 (1993).
    Article CAS Google Scholar
  13. O'Malley, F. et al. D.p53 mutations are confined to the comdeo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. Lab. Invest. 71, 67–72 (1994).
    CAS PubMed Google Scholar
  14. Giri, D., Dundas, S., Nottingham, J. & Underwood, J. Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: An immunohistological study. Histopathology 15, 575–584 (1989).
    Article CAS Google Scholar
  15. Bur, M., Zimarowski, M., Schnitt, S., Baker, S. & Lew, R. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer 69, 1174–1181 (1992).
    Article CAS Google Scholar
  16. O'Connell, P., Pekkel, V., Fuqua, S., Osborne, C. & Allred, C. Molecular genetic studies of early breast cancer evolution. Breast Cancer Res. Treat. 32, 5–12 (1994).
    Article CAS Google Scholar
  17. Zhang, S.-Y., Camano, J., Cooper, F., Guo, X. & Klein-Szanto, A. Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. clin. Path. 102, 695–698 (1994).
    Article CAS Google Scholar
  18. Gillett, C. et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54, 1812–1817 (1994).
    CAS PubMed Google Scholar
  19. Bartkova, J. et al. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57, 353–361 (1994).
    Article CAS Google Scholar
  20. Wang, T. et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369, 669–671 (1994).
    Article CAS Google Scholar
  21. Sicinski, P. et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621–630 (1995).
    Article CAS Google Scholar
  22. Han, E.K.-H. et al. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 10, 953–961 (1995).
    CAS PubMed Google Scholar
  23. Musgrove, E., Lee, C., Buckley, M. & Sutherland, R. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. natn. Acad. Sci. U.S.A. 91, 8022–8026 (1994).
    Article CAS Google Scholar
  24. Xiong, Y., Connolly, T., Futcher, B. & Beach, D. D-type cyclin. Cell 65, 691–699 (1991).
    Article CAS Google Scholar
  25. Pines, J. & Hunter, T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature 346, 760–763 (1990).
    Article CAS Google Scholar
  26. Lukas, J., Pagano, M., Staskova, Z., Draetta, G. & Bartek, J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9, 707–718 (1994).
    CAS PubMed Google Scholar

Download references